Table 4 Description of improvement in individual symptoms post- treatment by treatment type and results of association tests
Treatment | |||||||
|---|---|---|---|---|---|---|---|
Variable | SRS | SRT | Total | p | |||
n | % | n | % | n | % | ||
Pain Frontal/Facial/Paresthesia (V PAR-V1/V2) | 0.550 | ||||||
No | 32 | 100.0 | 54 | 94.7 | 86 | 96.6 | |
Yes | 0 | 0.0 | 3 | 5.3 | 3 | 3.4 | |
Epilepsy | 0.127 | ||||||
No | 30 | 93.8 | 57 | 100.0 | 87 | 97.8 | |
Yes | 2 | 6.3 | 0 | 0.0 | 2 | 2.2 | |
Cognitive/Dysthymic Alteration | 0.131 | ||||||
No | 29 | 90.6 | 56 | 98.2 | 85 | 95.5 | |
Yes | 3 | 9.4 | 1 | 1.8 | 4 | 4.5 | |
Decreased Visual Acuity-AMBLYOPIA | 0.820* | ||||||
No | 20 | 62.5 | 37 | 64.9 | 57 | 64.0 | |
Yes | 12 | 37.5 | 20 | 35.1 | 32 | 36.0 | |
Visual Fields | 0.522* | ||||||
No | 18 | 56.3 | 36 | 63.2 | 54 | 60.7 | |
Yes | 14 | 43.8 | 21 | 36.8 | 35 | 39.3 | |
Proptosis | 0.360 | ||||||
No | 31 | 96.9 | 57 | 100.0 | 88 | 98.9 | |
Yes | 1 | 3.1 | 0 | 0.0 | 1 | 1.1 | |
Palpebral Ptosis (III PAR) + Divergent Strabismus) | 0.233* | ||||||
No | 25 | 78.1 | 50 | 87.7 | 75 | 84.3 | |
Yes | 7 | 21.9 | 7 | 12.3 | 14 | 15.7 | |
Diplopiaa | 0.363 | ||||||
No | 29 | 90.6 | 47 | 82.5 | 76 | 85.4 | |
Yes | 3 | 9.4 | 10 | 17.5 | 13 | 14.6 | |
Unilateral mydriasis unreactive to light- Anisocoria | >0.999 | ||||||
No | 28 | 87.5 | 50 | 87.7 | 78 | 87.6 | |
Yes | 4 | 12.5 | 7 | 12.3 | 11 | 12.4 | |
Total | 32 | 100 | 57 | 100 | 89 | 100 | |